PCA3 Molecular Urine Assay for Prostate Cancer in Men Undergoing Repeat Biopsy
Top Cited Papers
- 31 March 2007
- journal article
- research article
- Published by Elsevier BV in Urology
- Vol. 69 (3), 532-535
- https://doi.org/10.1016/j.urology.2006.12.014
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- APTIMA PCA3 Molecular Urine Test: Development of a Method to Aid in the Diagnosis of Prostate CancerClinical Chemistry, 2006
- Prostate-Specific Antigen: Update 2006Urology, 2006
- Cancer Statistics, 2006CA: A Cancer Journal for Clinicians, 2006
- Predictive Probability of Serum Prostate-Specific Antigen for Prostate CancerAmerican Journal of Clinical Pathology, 2006
- Operating Characteristics of Prostate-Specific Antigen in Men With an Initial PSA Level of 3.0 ng/mL or LowerJAMA, 2005
- THE PROSTATE SPECIFIC ANTIGEN ERA IN THE UNITED STATES IS OVER FOR PROSTATE CANCER: WHAT HAPPENED IN THE LAST 20 YEARS?Journal of Urology, 2004
- DD3PCA3 RNA Analysis in Urine – A New Perspective for Detecting Prostate CancerEuropean Urology, 2004
- uPM3, a new molecular urine test for the detection of prostate cancerUrology, 2004
- Highly Sensitive Multiplex Assay for Detection of Human Immunodeficiency Virus Type 1 and Hepatitis C Virus RNAJournal of Clinical Microbiology, 2002
- Serial Biopsy Results in Prostate Cancer Screening StudyJournal of Urology, 2002